The Genus Yersinia pp 376-386
Cell-Mediated Defense Against Yersinia pestis Infection
Yersinia pestis (Yp) - one of the world’s most deadly human pathogens - is the gram-negative bacterium that causes pneumonic plague. Virulent antibiotic-resistant Yp strains exist and Cold War scientists devised means to effectively aerosolize Yp. These facts raise grave concern that Yp will be exploited as a bioweapon. To counter that possibility, it is essential that we develop a safe and effective pneumonic plague vaccine. Recent studies suggest that the leading vaccine candidate, which primarily stimulates antibody-mediated humoral immunity, may not suffice. T cell-dependent cellular immunity comprises a second means by which vaccines prime long-lived protection against virulent bacterial pathogens. However, a plasmid carried by virulent Yp encodes factors that dampen inflammation and debilitate phagocytes, thereby compromising cellular defense mechanisms. As such, plague vaccine researchers have devoted relatively little attention to cellular immunity. Here we review our recent work demonstrating that the passive transfer of primed T cells can suffice to protect mice against lethal intranasal Yp infection, a model of pneumonic plague. We also demonstrate that key elements of cellular immunity even play critical roles during antibody-mediated defense against plague. We conclude that next-generation plague vaccines should strive to prime both cellular and humoral immunity.
Unable to display preview. Download preview PDF.
- Alibek, K. (1999) Biohazard. Random House, Inc., New York.Google Scholar
- Brubaker, R.R. (2000) Yersinia pestis and bubonic plague. In The prokaryotes, an evolving electronic resource for the microbiological community. Dworkin, M., Falkow, S., Rosenberg, E., Schleifer, K.-H., and Stackebrandte, E. (eds.) Springer-Verlag, New York, http://22.214.171.124:8080/prokPUB/chaprender/jsp/showchap.jsp?chapnum=265.
- Friedlander, A.M., Welkos, S.L., Worsham, P.L., Andrews, G.P., Heath, D.G., Anderson, G.W., Jr., Pitt, M.L., Estep, J. and Davis, K. (1995) Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin. Infect. Dis. 21 Suppl 2, S178-181.Google Scholar
- Girard, G. (1963) Immunity in plague. Results of 30 years of work on the “Pasteurella pestis Ev” (Girard and Robic) strain. Biol. Med. (Paris). 52, 631-731.Google Scholar
- Green, M., Rogers, D., Russell, P., Stagg, A.J., Bell, D.L., Eley, S.M., Titball, R.W. and Williamson, E.D. (1999) The SCID/Beige mouse as a model to investigate protection against Yersinia pestis. FEMS Immunol. Med. Microbiol. 23, 107-113.Google Scholar
- Parent, M.A., Wilhelm, L.B., Kummer, L.W., Szaba, F.M., Mullarky, I.K. and Smiley, S.T. (2006) Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral de-fense against lethal pulmonary Yersinia pestis infection. Infect. Immun. 74, 3381-3386.CrossRefPubMedGoogle Scholar
- Perry, R.D. and Fetherston, J.D. (1997) Yersinia pestis-etiologic agent of plague. Clin. Micro-biol. Rev. 10, 35-66.Google Scholar
- Philipovskiy, A.V. and Smiley, S.T. (2007) Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection. Infect. Immun. In press.Google Scholar
- Pitt, M.L. (2004) Non-human primates as a model for pneumonic plague. Animals Models and Correlates of Protection for Plague Vaccines Workshop. Gaithersburg, MD, http://www.fda.gov/cber/minutes/plague101304t.pdf.
- Titball, R.W. and Williamson, E.D. (2004) Yersinia pestis (plague) vaccines. Expert Opin. Biol. Ther. 4, 965-973.Google Scholar